Linked by Thom Holwerda on Sun 25th Mar 2012 19:44 UTC
Legal "Last week a large, profitable company sued a small start-up business for patent infringement. As a non-legal person, I can only guess that this sort of thing must happen fairly often. I would also guess that the large companies, which have the means to hire crackerjack legal teams and drag cases out, must often win. And while I guess I feel bad for the small businesses, I've never really cared before now. Because this time, the stakes are high. This time, it's my daughter's voice on the line. Literally." Infuriating. Maybe these are the kinds of stories we need to get normal people to care enough to force lawmakers to change. Sadly, the big bags of money from Apple, Microsoft, and Oracle are probably far more important to them than this sad story.
Thread beginning with comment 511893
To view parent comment, click here.
To read all comments associated with this story, please click here.
RE[3]: Comment by shmerl
by ilovebeer on Mon 26th Mar 2012 06:57 UTC in reply to "RE[2]: Comment by shmerl"
Member since:

There are two side effects to that, drugs companies pushes new medicine even if they don't have better effects, just because they get higher profit from their patented drugs, second side effect, dugs companies mostly invest in medicine in area with high profit (such as anti-depressor, weight losing...), for problems affecting wealthy people who can make afford to pay a lot of money on drugs, meaning western countries.

First, only 3 of the top 10 richest countries in the world are western. Additionally, in most cases getting drugs approved here by the FDA is far harder than the EMA in Europe. What does that mean? It means the European market is very lucrative for drug companies.

Research & development of new drugs is astronomically expensive. While drug companies certainly may _potentially_ make enormous profits, they operate in a very high risk field in terms of investment. Naturally they have to focus on drugs with higher chances of payoff. This is not just for profit, it's also for survival for many drug companies.

Research on new drugs should be public, paid by a tax on drugs sell, and companies should compete on their ability to lower the production cost.

While that sounds good on paper, like many other ideas, it doesn't translate well in the real world. By reducing drug companies to mere manufacturing operations, you will essentially kill the same R&D competitiveness that has created many of the great drugs we have today. Remember, that insanely expensive R&D is paid for by those high prices. You take that away and you've cut off the very means by which new drugs are created.

Reply Parent Score: 2